Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Photocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107899611B details bifunctional catalysts combining cinchona alkaloids and porphyrins for visible-light driven asymmetric synthesis, offering greener pharmaceutical intermediate production.
Patent CN111072555A details a green HEH-catalyzed method for heterocyclic sulfones, offering cost reduction and supply chain reliability for pharma intermediates.
Patent CN110386885A enables metal-free visible light synthesis of β-carbonyl sulfones. Achieve cost reduction in fine chemical manufacturing with scalable, green protocols.
Patent CN115611756B reveals visible light catalysis for glycine derivatives, offering cost reduction in agrochemical manufacturing and high-purity supply chain solutions.
Patent CN115611756B reveals a visible-light photocatalytic method for α-substituted glycine derivatives, offering mild conditions and scalable agrochemical intermediate manufacturing.
Patent CN112441875B reveals a green copper photocatalytic route for 9-trifluoromethyl-9,10-dihydrophenanthrene, offering mild conditions and high atom economy for pharmaceutical intermediates.
Patent CN116283699B reveals a visible-light driven method for high-purity fluoroalkyl pyrrolidines offering significant cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN112574056B reveals a green photocatalytic route for alpha,alpha-difluoro-gamma-hydroxyacetamide derivatives, offering cost reduction and scalable manufacturing for pharma.
Patent CN110483346B reveals a visible-light photocatalytic method for synthesizing sulfonyl-substituted alpha-cyclopropyl styrenes, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN114853707A details a novel photocatalytic route for difluoromethylated 2,3-dihydrobenzopyran-4-ones, offering safer reagents and commercial scalability for pharmaceutical intermediates.
Novel blue-light mediated synthesis of 3-thioether quinoxalinones offers high purity and scalable routes for complex pharmaceutical intermediates manufacturing.
Patent CN106317065B enables green photocatalytic synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing globally.
Patent CN116396315A details a mild visible-light method for 1,4-dihydronaphthalenes, offering cost-effective routes for pharmaceutical intermediates.
Patent CN115785052B reveals high-selectivity isocoumarin synthesis. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Novel photocatalytic method for thietane indoline heterocycles. High yield, mild conditions, scalable for pharmaceutical intermediates manufacturing.
Patent CN112375102B details a green visible-light catalyzed method for synthesizing phosphonylated imidazopyridines, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN111689912A reveals a metal-free g-C3N4 photocatalytic route for quinoxalinones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115925609A details a green FeCl2-catalyzed route to 3-alkenyl oxindoles. This method offers significant cost reduction and supply chain reliability for API manufacturing.
Patent CN109503472B details a mild, two-step photocatalytic route for heterocyclic sulfones. Achieve high purity and cost reduction in fine chemical manufacturing with scalable methods.
Novel Pd-catalyzed visible light method for SuFEx warheads. High purity pharmaceutical intermediates with scalable green chemistry processes.